The changing diagnostic testing paradigm
Despite laboratories’ longstanding reliance upon microbial culture for infectious disease identification, the pressures of the pandemic have incre...
Source: labnews.co.uk
Accelerated Access Collaborative News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Accelerated Access Collaborative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Accelerated Access Collaborative Today - Breaking & Trending Today
Inclisiran: Government's strategy to promote cholesterol lowering drug after Brexit was "spectacular failure," says insider
The government’s policy to fast track “innovative” drugs into the NHS to showcase the UK as a great place for industry has been described as “a pretty spectacular failure,” because of the way a test case using the cholesterol lowering drug inclisiran was received. The rapid introduction of inclisiran into the UK was part of the government’s drive to help the country regain its “status as a science superpower” after Brexit,1 which would bypass some of the usual routes to getting a drug into clinical practice. The policy was widely supported across government, including by the De...
Source: bmj.com
Inclisiran: the 'extremely unusual' political influence behind the novel drug's approval
The Pharmaceutical Journal from the Royal Pharmaceutical Society
Source: pharmaceutical-journal.com
PJ view: Transparency in the science behind government policy is vital
The Pharmaceutical Journal from the Royal Pharmaceutical Society
Source: pharmaceutical-journal.com
Global Pharmaceutical Regulatory Affairs Industry Report 2023-2030 Featuring Freyr, IQVIA, ICON, WuXi AppTec, Charles River, Labcorp, Parexel, Pharmalex, Pharmexon, Genpact
/PRNewswire/ -- The "Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Services, By Category, By Service Provider, By Company...
Source: prnewswire.com